- Home
- ECOR vs SERA Comparison
ECOR vs SERA Comparison
Compare ECOR & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ECOR | SERA |
|---|---|---|
| Founded | 2005 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Precision Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.0M | 75.2M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ECOR | SERA |
|---|---|---|
| Price | $9.37 | $2.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | ★ 72.2K | 39.3K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.32 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $32,032,000.00 | $81,000.00 |
| Revenue This Year | $33.60 | $554.81 |
| Revenue Next Year | $30.40 | $517.27 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 27.20 | 5.19 |
| 52 Week Low | $4.41 | $1.56 |
| 52 Week High | $10.50 | $3.95 |
Technical Indicators
Market Signals| Indicator | ECOR | SERA |
|---|---|---|
| Relative Strength Index (RSI) | 72.06 | 48.31 |
| Support Level | $8.55 | $1.68 |
| Resistance Level | $9.53 | $2.07 |
| Average True Range (ATR) | 0.78 | 0.17 |
| MACD | 0.42 | -0.01 |
| Stochastic Oscillator | 89.01 | 37.28 |
Price Performance
Historical ComparisonAbout ECOR electroCore Inc.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.